280 related articles for article (PubMed ID: 33284538)
1. Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities.
Maluf F; Soares A; Avanço G; Hada AL; Cardoso APG; Carneiro A; Herchenhorn D; Jardim DLF; Schutz FA; Kater FR; Pereira FMT; Monteiro FSM; Morbeck IAP; Reolon JFN; da Trindade KM; Andrade LMQDS; Nogueira LM; Furoni R; Natel RA; Dos Reis RB; Fogace RN; Souza VC
Int Braz J Urol; 2021; 47(2):359-373. PubMed ID: 33284538
[TBL] [Abstract][Full Text] [Related]
2. Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
Gillessen S; Bossi A; Davis ID; de Bono J; Fizazi K; James ND; Mottet N; Shore N; Small E; Smith M; Sweeney CJ; Tombal B; Antonarakis ES; Aparicio AM; Armstrong AJ; Attard G; Beer TM; Beltran H; Bjartell A; Blanchard P; Briganti A; Bristow RG; Bulbul M; Caffo O; Castellano D; Castro E; Cheng HH; Chi KN; Chowdhury S; Clarke CS; Clarke N; Daugaard G; De Santis M; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ekeke ON; Evans CP; Fanti S; Feng FY; Fonteyne V; Fossati N; Frydenberg M; George D; Gleave M; Gravis G; Halabi S; Heinrich D; Herrmann K; Higano C; Hofman MS; Horvath LG; Hussain M; Jereczek-Fossa BA; Jones R; Kanesvaran R; Kellokumpu-Lehtinen PL; Khauli RB; Klotz L; Kramer G; Leibowitz R; Logothetis C; Mahal B; Maluf F; Mateo J; Matheson D; Mehra N; Merseburger A; Morgans AK; Morris MJ; Mrabti H; Mukherji D; Murphy DG; Murthy V; Nguyen PL; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Pezaro CJ; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin MA; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Sharifi N; Skoneczna I; Soule H; Spratt DE; Srinivas S; Sternberg CN; Steuber T; Suzuki H; Sydes MR; Taplin ME; Tilki D; Türkeri L; Turco F; Uemura H; Uemura H; Ürün Y; Vale CL; van Oort I; Vapiwala N; Walz J; Yamoah K; Ye D; Yu EY; Zapatero A; Zilli T; Omlin A
Eur J Cancer; 2023 May; 185():178-215. PubMed ID: 37003085
[TBL] [Abstract][Full Text] [Related]
3. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
Gillessen S; Bossi A; Davis ID; de Bono J; Fizazi K; James ND; Mottet N; Shore N; Small E; Smith M; Sweeney C; Tombal B; Antonarakis ES; Aparicio AM; Armstrong AJ; Attard G; Beer TM; Beltran H; Bjartell A; Blanchard P; Briganti A; Bristow RG; Bulbul M; Caffo O; Castellano D; Castro E; Cheng HH; Chi KN; Chowdhury S; Clarke CS; Clarke N; Daugaard G; De Santis M; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ngozi Ekeke O; Evans CP; Fanti S; Feng FY; Fonteyne V; Fossati N; Frydenberg M; George D; Gleave M; Gravis G; Halabi S; Heinrich D; Herrmann K; Higano C; Hofman MS; Horvath LG; Hussain M; Jereczek-Fossa BA; Jones R; Kanesvaran R; Kellokumpu-Lehtinen PL; Khauli RB; Klotz L; Kramer G; Leibowitz R; Logothetis CJ; Mahal BA; Maluf F; Mateo J; Matheson D; Mehra N; Merseburger A; Morgans AK; Morris MJ; Mrabti H; Mukherji D; Murphy DG; Murthy V; Nguyen PL; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Pezaro C; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin MA; Ryan CJ; Saad F; Pablo Sade J; Sartor OA; Scher HI; Sharifi N; Skoneczna I; Soule H; Spratt DE; Srinivas S; Sternberg CN; Steuber T; Suzuki H; Sydes MR; Taplin ME; Tilki D; Türkeri L; Turco F; Uemura H; Uemura H; Ürün Y; Vale CL; van Oort I; Vapiwala N; Walz J; Yamoah K; Ye D; Yu EY; Zapatero A; Zilli T; Omlin A
Eur Urol; 2023 Mar; 83(3):267-293. PubMed ID: 36494221
[TBL] [Abstract][Full Text] [Related]
4. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
Gillessen S; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Chi KN; Clarke N; Davis ID; de Bono J; Drake CG; Duran I; Eeles R; Efstathiou E; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; Gleave M; Halabi S; Heidenreich A; Heinrich D; Higano CTS; Hofman MS; Hussain M; James N; Kanesvaran R; Kantoff P; Khauli RB; Leibowitz R; Logothetis C; Maluf F; Millman R; Morgans AK; Morris MJ; Mottet N; Mrabti H; Murphy DG; Murthy V; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Parker C; Poon DMC; Pritchard CC; Reiter RE; Roach M; Rubin M; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Shore N; Small E; Smith M; Soule H; Sternberg CN; Steuber T; Suzuki H; Sweeney C; Sydes MR; Taplin ME; Tombal B; Türkeri L; van Oort I; Zapatero A; Omlin A
Eur Urol; 2020 Apr; 77(4):508-547. PubMed ID: 32001144
[TBL] [Abstract][Full Text] [Related]
5. Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
Luz MA; Guimarães GC; Nardi AC; Pompeo ASFL; Sarkis ÁS; Nowier A; Lima Pompeo AC; Nardozza A; Adamy A; Carneiro A; Salvajoli BP; Benigno BS; Freitas CH; Chade CADC; Palhares DMF; Otero DAC; Neto DCVDS; Carvalhal EF; Gil E; Freire de Arruda F; Korkes F; Caserta Lemos G; Carvalhal GF; de Carvalho ÍT; Gimpel IFP; Chambô JL; Pontes J; Filho LAR; Nogueira LM; Wroclawski ML; Freitas MRP; Arap MA; Sadi MV; Bulbul M; Coelho RF; Gadia R; Khauli RB; Dos Reis RB; Rojas RAL; Guimarães RG; Aldousari S; Ferrigno R
JCO Glob Oncol; 2021 Apr; 7():523-529. PubMed ID: 33856894
[TBL] [Abstract][Full Text] [Related]
6. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.
Gillessen S; Armstrong A; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Bulbul M; Caffo O; Chi KN; Clarke CS; Clarke N; Davis ID; de Bono JS; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ekeke ON; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; George D; Gleave M; Halabi S; Heinrich D; Higano C; Hofman MS; Hussain M; James N; Jones R; Kanesvaran R; Khauli RB; Klotz L; Leibowitz R; Logothetis C; Maluf F; Millman R; Morgans AK; Morris MJ; Mottet N; Mrabti H; Murphy DG; Murthy V; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Parker C; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin M; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Shore N; Skoneczna I; Small E; Smith M; Soule H; Spratt DE; Sternberg CN; Suzuki H; Sweeney C; Sydes MR; Taplin ME; Tilki D; Tombal B; Türkeri L; Uemura H; Uemura H; van Oort I; Yamoah K; Ye D; Zapatero A; Omlin A
Eur Urol; 2022 Jul; 82(1):115-141. PubMed ID: 35450732
[TBL] [Abstract][Full Text] [Related]
7. Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology.
Gómez-Caamaño A; González-San Segundo C; Henríquez I; Maldonado X; Zapatero A;
Clin Transl Oncol; 2019 Apr; 21(4):420-432. PubMed ID: 30293231
[TBL] [Abstract][Full Text] [Related]
8. Consensus on Screening, Diagnosis, and Staging Tools for Prostate Cancer in Developing Countries: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
Carneiro A; Racy D; Bacchi CE; Leite KRM; Filippi RZ; Martins IAF; Salvajoli JV; Hanriot RM; Baroni RH; Sarkis AS; Pompeo ACL; Benigno BS; Guimarães GC; Aldousari S; Nardi AC; Pompeo ASFL; Nowier A; Nardozza A; Adamy A; Freitas CH; Chade DC; Otero DAC; Neto DCVDS; Carvalhal EF; Korkes F; Ferrigno R
JCO Glob Oncol; 2021 Apr; 7():516-522. PubMed ID: 33856895
[TBL] [Abstract][Full Text] [Related]
9. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
Gillessen S; Attard G; Beer TM; Beltran H; Bossi A; Bristow R; Carver B; Castellano D; Chung BH; Clarke N; Daugaard G; Davis ID; de Bono J; Borges Dos Reis R; Drake CG; Eeles R; Efstathiou E; Evans CP; Fanti S; Feng F; Fizazi K; Frydenberg M; Gleave M; Halabi S; Heidenreich A; Higano CS; James N; Kantoff P; Kellokumpu-Lehtinen PL; Khauli RB; Kramer G; Logothetis C; Maluf F; Morgans AK; Morris MJ; Mottet N; Murthy V; Oh W; Ost P; Padhani AR; Parker C; Pritchard CC; Roach M; Rubin MA; Ryan C; Saad F; Sartor O; Scher H; Sella A; Shore N; Smith M; Soule H; Sternberg CN; Suzuki H; Sweeney C; Sydes MR; Tannock I; Tombal B; Valdagni R; Wiegel T; Omlin A
Eur Urol; 2018 Feb; 73(2):178-211. PubMed ID: 28655541
[TBL] [Abstract][Full Text] [Related]
10. "Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil".
Jardim DL; Gonçalves E Silva A; Pompeo ASFL; Sarkis AS; Cardoso APG; Sasse AD; Fay AP; Soares A; Pompeo ACL; Carneiro A; Kann AG; Fogassa C; De Freitas CH; Chade DC; Herchenhorn D; De Almeida DVP; Da Rosa DAR; Wiermann EG; Schutz FAB; Kater FR; De Moura F; Korkes F; Meyer F; De Oliveira FNG; Sabino F; Almeida GL; Avanço G; Guimaraes GC; Lemos GC; Carvalhal GF; Kim H; Morbeck IP; Campagnari JC; Rinck JA; Da Ponte JRT; Da Trindade KM; Atem L; Borges L; Nogueira LM; Batista LTEA; Maia MC; Sadi MV; Rocha MAA; Luz MA; Smaletz O; Lages PSM; Matuda RMK; Reis RBD; Indio RF; Fernandes RC; Cavallero SR; Souza VC; Busato W; Alfer W; Maluf F
Clin Genitourin Cancer; 2023 Apr; 21(2):e58-e69. PubMed ID: 36266221
[TBL] [Abstract][Full Text] [Related]
11. [Consensus on castration-resistant prostate cancer management in Spain.].
Alcaraz A; Martínez-Piñeiro L; Rodríguez A; Rubio J; Borque Á; Burgos J; Carballido J; Cózar JM; Crespo I; Esquena S; Gómez-Veiga F; López D; Miñana B; Morote J; Ribal MJ; Solsona E; Suárez JF; Unda M
Arch Esp Urol; 2017 Nov; 70(9):777-791. PubMed ID: 29099380
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?
Marra G; Calleris G; Alessio P; Oderda M; Palou J; Joniau S; Piechaud T; Smelzo S; Morlacco A; Sharma V; Tilki D; Van der Poel H; Veerman H; Karnes RJ; Gontero P
Eur Urol Focus; 2021 Jul; 7(4):807-811. PubMed ID: 32414618
[TBL] [Abstract][Full Text] [Related]
13. A urologic oncology roundtable discussion: issues to consider in choosing treatment for metastatic castration-resistant prostate cancer.
Taplin ME; Berry WR; Casey AM; Aslo A
Hosp Pract (1995); 2013; 41(4):81-2. PubMed ID: 24145593
[TBL] [Abstract][Full Text] [Related]
14. Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer-going beyond PSA and imaging, a systematic literature review.
Schmid S; Omlin A; Blum D; Strasser F; Gillessen S; Rothermundt C
Ann Oncol; 2015 Nov; 26(11):2221-47. PubMed ID: 26216388
[TBL] [Abstract][Full Text] [Related]
15. Estimating high-risk castration resistant prostate cancer (CRPC) using electronic health records.
Hernandez RK; Cetin K; Pirolli M; Quigley J; Quach D; Smith P; Stryker S; Liede A
Can J Urol; 2015 Aug; 22(4):7858-64. PubMed ID: 26267023
[TBL] [Abstract][Full Text] [Related]
16. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries.
Khauli R; Ferrigno R; Guimarães G; Bulbulan M; Uson Junior PLS; Salvajoli B; Palhares DMF; Racy D; Gil E; de Arruda FF; Lemos GC; Carvalhal GF; de Carvalho IT; Martins IAF; Gimpel IFP; Salvajoli JV; Chambo JL; Pontes J; Filho LAR; Nogueira L; Freitas MRP; Wroclawski M; Arap MA; Sadi MV; Coelho R; Gadia R; Roja RAL; Hanriot RM; Baroni R; Zequi S; Nahas WC; Alfer W; Maluf FC
JCO Glob Oncol; 2021 Apr; 7():530-537. PubMed ID: 33856890
[TBL] [Abstract][Full Text] [Related]
18. Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment.
Anantharaman A; Small EJ
Expert Rev Anticancer Ther; 2017 Jul; 17(7):625-633. PubMed ID: 28532278
[TBL] [Abstract][Full Text] [Related]
19. Symptoms and Impacts in Non-Metastatic Castration-Resistant Prostate Cancer: Qualitative Study Findings.
Tomaszewski EL; Moise P; Krupnick RN; Downing J; Meyer M; Naidoo S; Holmstrom S
Patient; 2017 Oct; 10(5):567-578. PubMed ID: 28285412
[TBL] [Abstract][Full Text] [Related]
20. Treatment patterns and characteristics of European patients with castration-resistant prostate cancer.
Sternberg CN; Baskin-Bey ES; Watson M; Worsfold A; Rider A; Tombal B
BMC Urol; 2013 Nov; 13():58. PubMed ID: 24206580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
